Review article: management of hepatic disease following haematopoietic cell transplant

Aliment Pharmacol Ther. 2006 Aug 1;24(3):441-52. doi: 10.1111/j.1365-2036.2006.03001.x.

Abstract

Hepatic diseases are common complications of haematopoietic cell transplant. The causes are multiple: myeloablative conditioning regimens may cause sinusoidal injury; acute and chronic graft-versus-host disease lead to damaged hepatocytes and small bile ducts; microcrystalline deposits in the gall bladder can cause biliary symptoms; drug-induced liver injury is common; and the liver may be infected by viruses and fungi during the period of severe immune suppression that follows transplant. Pre-transplant evaluation and prevention of liver injury are often more useful than treatment of deeply jaundiced patients in improving transplant outcomes. This review covers pre-transplant evaluation, common hepatobiliary problems in the six months following transplant, and hepatic problems in long-term survivors.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Liver Diseases / etiology*
  • Liver Diseases / prevention & control
  • Virus Diseases / etiology*